Ethanolic Extracts of <i>Brassica campestris</i> spp. <i>rapa</i> Roots Prevent High-Fat Diet-Induced Obesity via <i>β</i> <sub>3</sub> -Adrenergic Regulation of White Adipocyte Lipolytic Activity

Sojin An, Jang-Il Han, Minjung Kim, Ji‐Seon Park, Jongmin Han, Nam‐In Baek, Hae‐Gon Chung, Myung‐Sook Choi, Kyung‐Tae Lee, Tae‐Sook Jeong

Journal of Medicinal Food · 2010 · 39 citations · 21 references

Concepts

Abstract

The influence of ethanolic extracts of Brassica campestris spp. rapa roots (EBR) on obesity was examined in imprinting control region (ICR) mice fed a high-fat diet (HFD) and in 3T3-L1 adipocytes. The ICR mice used were divided into regular diet, HFD, EBR (50 mg/kg/day EBR administered orally), and orlistat (10 mg/kg/day orlistat administered orally) groups. The molecular mechanism of the anti-obesity effect of EBR was investigated in 3T3-L1 adipocytes as well as in HFD-fed ICR mice. In the obese mouse model, both weight gain and epididymal fat accumulation were highly suppressed by the daily oral administration of 50 mg/kg EBR for 8 weeks, whereas the overall amount of food intake was not affected. EBR treatment induced the expression in white adipocytes of lipolysis-related genes, including beta(3)-adrenergic receptor (beta(3)-AR), hormone-sensitive lipase (HSL), adipose triglyceride lipase, and uncoupling protein 2. Furthermore, the activation of cyclic AMP-dependent protein kinase, HSL, and extracellular signal-regulated kinase was induced in EBR-treated 3T3-L1 cells. The lipolytic effect of EBR involved beta(3)-AR modulation, as inferred from the inhibition by the beta(3)-AR antagonist propranolol. These results suggest that EBR may have potential as a safe and effective anti-obesity agent via the inhibition of adipocyte lipid accumulation and the stimulation of beta(3)-AR-dependent lipolysis.

References

21